Authors


Kevin Fiscella, MD, MPH

Latest:

Cost-Effectiveness of Intensive Tobacco Dependence Intervention Based on Self-Determination Theory

An intensive tobacco dependence intervention based on selfdetermination theory that targeted all smokers was cost-effective and facilitated patient autonomy, perceived competence, and long-term tobacco abstinence.



Linda L. Sanders, MPH

Latest:

Evaluation of a Packaging Approach to Improve Cholesterol Medication Adherence

A 7.6% improvement in 12-month cholesterol refill was observed among US military veterans randomized to an adherence blister packaging intervention versus an education-only intervention.


Jody M. Jackson, RN, BSN

Latest:

Knowledge, Attitudes, and Preferences Regarding Advance Directives Among Patients of a Managed Care Organization

Adults 20 years or older were surveyed regarding advance directives (ADs); one third had completed an AD. Subjects were comfortable with provider initiation of the topic.


Laura C. Collins, MBBS

Latest:

Treatment of Ductal Carcinoma In Situ Among Patients Cared for in Large Integrated Health Plans

Although we found no DCIS treatment disparities by race/ethnicity, use of adjuvant radiation therapy was less among older women and among residents of poorer neighborhoods.




Robert Lindsay, MD

Latest:

Therapies for Treatment of Osteoporosis in US Women: Cost-effectiveness and Budget Impact Considerations

Osteoporosis treatment for high-risk women is cost-effective, with bisphosphonates providing the most benefit at the lowest cost.



Laurel Barosh, MPH

Latest:

Bridging the Care Gap Between Pediatric and Young Adult Cancer

Through a multi-site, multidisciplinary approach, AYA@USC addresses the unique needs of young adult cancer patients, improving outcomes and bridging the care gap in this population.


Beverly Shaw, MS

Latest:

Practical Solutions When Facing Cost Sharing: The American Cancer Society's Health Insurance Assistance Service

This case study from the American Cancer Society (ACS) describes the ACS’s Health Insurance Assistance Service and offers profiles of 2 cases, which describe the challenges of finding adequate and affordable solutions, as well as sharing lessons learned.


Heather Zierhut, PhD, MS, CGC

Latest:

The Impact of New CMS Rules for Telehealth on Cancer Genetic Counseling

Telehealth, a universal term for the use of digital information and communication technologies to remotely access healthcare services, is improving availability of healthcare services, particularly for patients in rural areas.


Bronwyn Starr, MPH

Latest:

Medicare Underpayment for Diabetes Prevention Program: Implications for DPP Suppliers

The actual costs of implementing the evidence-based Diabetes Prevention Program (DPP) were compared with the latest reimbursement rates provided by CMS.



Sharon Hensley Alford, PhD

Latest:

Utilization of HER2 Genetic Testing in a Multi-Institutional Observational Study

Evaluation of real-world implementation of HER2 testing showed that uptake was high (>90%) and trastuzumab treatment was targeted to patients with positive HER2 status.



Ran Balicer, MD, PhD, MPH

Latest:

Analyzing Admission Rates for Multiple Ambulatory Care–Sensitive Conditions

Ambulatory care–sensitive conditions can be systematically assessed in a large electronic medical database to describe admission rates by year, catchment area, and hospital affiliation.


David B. Snow, Jr.

Latest:

Prescription for National Healthcare Reform

Widespread adoption of evidence-based protocols and healthy lifestyles provide a combined opportunity to reduce up to $1 trillion of current healthcare spending.



Deborah Peikes, PhD

Latest:

Early Evaluations of the Medical Home: Building on a Promising Start

Findings from a systematic evidence review of the medical home are promising, but indicate the critical need for stronger evaluations to guide policy makers.




Brian Connell

Latest:

Solutions for Reducing Patient Cost Sharing for Medications

Cost sharing for medications presents a serious access barrier for many blood cancer patients. Available solutions, if embraced by policymakers, could reduce such cost sharing with very little impact on premiums.


J. Ross Maclean, MD

Latest:

Value-Based Insurance Design: Benefits Beyond Cost and Utilization

The authors provide a framework to capture additional benefits that may result from VBID programs, extending beyond utilization and outcomes to productivity, engagement, and talent.







AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo